Marcos Palatnik

1.1k total citations
28 papers, 970 citations indexed

About

Marcos Palatnik is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, Marcos Palatnik has authored 28 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 16 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Marcos Palatnik's work include Research on Leishmaniasis Studies (20 papers), Trypanosoma species research and implications (16 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Marcos Palatnik is often cited by papers focused on Research on Leishmaniasis Studies (20 papers), Trypanosoma species research and implications (16 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Marcos Palatnik collaborates with scholars based in Brazil, Italy and Germany. Marcos Palatnik's co-authors include M Palatnik, Edilma Paraguai de Souza, Gulnara Patrı́cia Borja-Cabrera, Dirlei Nico, Valéria Marçal Felix de Lima, Carlile Lavor, José Paz Parente, Ingrid Menz, Alexandre Morrot and L M Peçanha and has published in prestigious journals such as Frontiers in Immunology, Vaccine and PLoS neglected tropical diseases.

In The Last Decade

Marcos Palatnik

27 papers receiving 939 citations

Peers

Countries citing papers authored by Marcos Palatnik

Since Specialization

Citations

This map shows the geographic impact of Marcos Palatnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos Palatnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos Palatnik more than expected).

Fields of papers citing papers by Marcos Palatnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos Palatnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos Palatnik. The network helps show where Marcos Palatnik may publish in the future.

Co-authorship network of co-authors of Marcos Palatnik

This figure shows the co-authorship network connecting the top 25 collaborators of Marcos Palatnik. A scholar is included among the top collaborators of Marcos Palatnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcos Palatnik. Marcos Palatnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection 2017 ·Frontiers in Immunology ·(unknown), Dirlei Nico, Alexandre Morrot, Marcos Palatnik, M Palatnik	30
2	Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis 2017 ·Frontiers in Immunology ·(unknown), Dirlei Nico, (unknown), (unknown), (unknown), Eugenia Carrillo, Javier Moreno, Paula Mello De Luca, Alexandre Morrot, Daniela Santoro Rosa, Marcos Palatnik, Cristiane Bani Corrêa, Roque Pacheco de Almeida, M Palatnik	20
3	Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection 2014 ·Frontiers in Immunology ·Dirlei Nico, (unknown), (unknown), Alexandre Morrot, Marcos Palatnik, M Palatnik	26
4	Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains 2014 ·Frontiers in Immunology ·Dirlei Nico, (unknown), (unknown), (unknown), Alexandre Morrot, Diana Bahia, Marcos Palatnik, Maurício M. Rodrigues, M Palatnik	31
5	The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains 2012 ·Vaccine ·Dirlei Nico, Ricardo M. Borges, (unknown), Daniel F. Feijó, (unknown), Marcos Palatnik, Maurício M. Rodrigues, Antônio Jorge Ribeiro da Silva, M Palatnik	8
6	Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors 2012 ·Parasites & Vectors ·Dirlei Nico, Daniel F. Feijó, (unknown), Alexandre Morrot, Júlio Scharfstein, Marcos Palatnik, M Palatnik	10
7	Adaptive Immunity against Leishmania Nucleoside Hydrolase Maps Its C-Terminal Domain as the Target of the CD4+ T Cell–Driven Protective Response 2010 ·PLoS neglected tropical diseases ·Dirlei Nico, Carla Claser, Gulnara Patrı́cia Borja-Cabrera, Luiz R. Travassos, Marcos Palatnik, Irene S. Soares, Maurício M. Rodrigues, M Palatnik	43
8	Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas 2009 ·Vaccine ·M Palatnik, (unknown), (unknown), Ingrid Menz, Marcos Palatnik, Carlile Lavor	82
9	Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis 2004 ·Vaccine ·Bernadete Pereira da Silva, (unknown), Edilma Paraguai de Souza, Marcos Palatnik, M Palatnik, José Paz Parente	27
10	IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis 2003 ·Vaccine ·(unknown), Edilma Paraguai de Souza, Gulnara Patrı́cia Borja-Cabrera, (unknown), (unknown), (unknown), Ingrid Menz, Marcos Palatnik, M Palatnik	60
11	Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine 2003 ·Vaccine ·Gulnara Patrı́cia Borja-Cabrera, (unknown), Edilma Paraguai de Souza, (unknown), (unknown), (unknown), (unknown), Alexandre Barbosa Reis, Odair Genaro, (unknown), Marcos Palatnik, M Palatnik	116
12	Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine 2003 ·Vaccine ·(unknown), (unknown), Edilma Paraguai de Souza, Valéria Marçal Felix de Lima, Marcos Palatnik, M Palatnik	46
13	Analysis of the −1185A/G von Willebrand factor (VWF) gene polymorphism in two Brazilian ethnic groups and its effect on the plasma VWF levels 2002 ·Thrombosis Research ·Daniel Simon, Marcos Palatnik, Israel Roisenberg	10
14	Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis 2002 ·Vaccine ·(unknown), Valéria Marçal Felix de Lima, Edilma Paraguai de Souza, (unknown), Marcos Palatnik, M Palatnik	94
15	Occurrence of Leishmania donovani parasitemia in plasma of infected hamsters 2001 ·Acta Tropica ·Edilma Paraguai de Souza, Ana Paula Esteves Pereira, (unknown), (unknown), Thaïs Souto-Padrón, Marcos Palatnik, M Palatnik	15
16	Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani 2001 ·Vaccine ·Edilma Paraguai de Souza, Róbson Roney Bernardo, Marcos Palatnik, M Palatnik	46
17	Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani 1999 ·Vaccine ·(unknown), Edilma Paraguai de Souza, Marcos Palatnik, M Palatnik	46
18	The 60 and 63 kDa proteolytic peptides of the red cell membrane band-3 protein: their prevalence in human and non-human primates 1990 ·Human Genetics ·Marcos Palatnik, (unknown), (unknown), (unknown)	16
19	Duffy and duffy-related human antigens in primates 1984 ·Journal of Human Evolution ·Marcos Palatnik, Arthur W. Rowe	15
20	Inclusión citoplasmatica en las células urinarias de los pacientes afectados por la fiebre hemorragica epidémica del noroeste bonaerense 1960 ·Americanae (AECID Library) ·Marcos Palatnik	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact